Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-11 12:41 pm Purchase |
2023-11-30 | 13G | Benitec Biopharma Inc. BNTC |
FRANKLIN RESOURCES INC BEN |
588,237 22.900% |
2 (+0.00%) |
Filing History |
| 2023-09-11 11:27 am Purchase |
2023-08-31 | 13G | Benitec Biopharma Inc. BNTC |
FRANKLIN RESOURCES INC BEN |
588,235 28.500% |
588,235 (New Position) |
Filing History |
| 2023-08-25 4:30 pm Purchase |
2023-08-15 | 13G | Benitec Biopharma Inc. BNTC |
ADAGE CAPITAL PARTNERS GP LLC | 189,188 7.500% |
189,188 (New Position) |
Filing History |
| 2023-08-21 4:07 pm Purchase |
2023-08-11 | 13G | Benitec Biopharma Inc. BNTC |
Citadel Advisors LLC | 180,030 6.900% |
180,030 (New Position) |
Filing History |
| 2023-08-18 3:55 pm Purchase |
2023-08-09 | 13G | Benitec Biopharma Inc. BNTC |
JANUS HENDERSON GROUP PLC JHG |
206,170 9.900% |
206,170 (New Position) |
Filing History |
| 2023-08-18 10:50 am Sale |
2023-08-08 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 98,203 3.890% |
-24,395 (-19.90%) |
Filing History |
| 2023-04-18 4:16 pm Sale |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 177,660 9.990% |
-194,617 (-52.28%) |
Filing History |
| 2023-02-14 11:24 am Sale |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
CVI Investments, Inc. | 86,447 4.900% |
-1,789 (-2.03%) |
Filing History |
| 2023-02-13 12:25 pm Purchase |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 372,276 9.990% |
327,041 (+722.98%) |
Filing History |
| 2023-02-07 5:38 pm Sale |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SILVERARC CAPITAL MANAGEMENT LLC | 0 0.000% |
-34,559 (Position Closed) |
Filing History |
| 2022-10-11 12:05 pm Purchase |
2022-09-30 | 13G | Benitec Biopharma Inc. BNTC |
FRANKLIN RESOURCES INC BEN |
588,235 38.700% |
588,235 (New Position) |
Filing History |
| 2022-10-07 12:46 pm Purchase |
2022-09-14 | 13G | Benitec Biopharma Inc. BNTC |
Steven Michael Oliveira | 122,598 8.080% |
83,297 (+211.94%) |
Filing History |
| 2022-09-23 10:11 am Purchase |
2022-09-13 | 13G | Benitec Biopharma Inc. BNTC |
CVI Investments, Inc. | 88,235 5.800% |
88,235 (New Position) |
Filing History |
| 2022-02-10 09:09 am Unchanged |
2021-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% |
0 (Unchanged) |
Filing History |
| 2022-02-10 09:07 am Unchanged |
2021-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% |
0 (Unchanged) |
Filing History |
| 2022-02-09 4:39 pm Purchase |
2021-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SILVERARC CAPITAL MANAGEMENT LLC | 34,559 7.200% |
34,559 (New Position) |
Filing History |
| 2022-02-08 4:31 pm Sale |
2021-12-31 | 13G | Benitec Biopharma Inc. BNTC |
Hudson Bay Capital Management LP | 0 0.000% |
-21,034 (Position Closed) |
Filing History |
| 2022-01-13 10:53 am Sale |
2021-12-31 | 13G | Benitec Biopharma Inc. BNTC |
ALPHA CAPITAL AKTIENGESELLSCHAFT | 7,333 1.530% |
-7,741 (-51.35%) |
Filing History |
| 2021-05-07 4:46 pm Purchase |
2021-04-28 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 45,235 9.800% |
45,235 (New Position) |
Filing History |
| 2021-04-28 5:22 pm Purchase |
2021-04-28 | 13G | Benitec Biopharma Inc. BNTC |
Lincoln Park Capital Fund LLC | 24,913 5.392% |
24,913 (New Position) |
Filing History |